Filter the drugs by their status, phase of research and how they help

COVID-19 is respiratory dissease caused by SARS-CoV-2 virus. Browse the database of drugs treating specific mutations compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Remdesivir Emergency use authorization Experimental Antiviral Jul/07/2020 Jul/09/2020 0
Rupintrivir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/01/2020 Jul/03/2020 0
Influenza vaccine Potential treatment - clinical evidence Used to treat other disease Vaccine Jul/01/2020 Jul/03/2020 0
Tocilizumab Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/30/2020 Jul/03/2020 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/29/2020 Jun/30/2020 0
Tipiracil  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/28/2020 Jun/29/2020 0
Dexamethasone Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/27/2020 Jul/06/2020 0
MVA/S vaccine Potential treatment - pre-clinical evidence Experimental Vaccine Jun/27/2020 Jun/29/2020 0
Candidine  Potential treatment - theoretical effect Natural product Antiviral Jun/25/2020 Jun/29/2020 0
Thioflexibilolide A Potential treatment - theoretical effect Natural product Antiviral Jun/25/2020 Jun/29/2020 0